Ballentine Partners, LLC Royalty Pharma PLC Transaction History

Ballentine Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 11, 2024	BUY	$27.46 - $31.33 $11,148 - $12,719	406 Added 3.35%	12,541 $380,000
Q4 2023 Jan 23, 2024	BUY	$26.21 - $29.22 $318,058 - $354,584	12,135 New	12,135 $340,000
Q2 2022 Aug 09, 2022	SELL	$37.53 - $44.22 $485,337 - $571,853	-12,932 Closed	0 $0
Q1 2022 May 05, 2022	BUY	$37.46 - $42.44 $143,059 - $162,078	3,819 Added 41.91%	12,932 $504,000
Q4 2021 Feb 14, 2022	BUY	$35.17 - $42.48 $320,504 - $387,120	9,113 New	9,113 $363,000

412

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11.2B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Ballentine Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Ballentine Partners, LLC with notifications on news.